Omicron’s seemingly lower impact on respiratory function than previous variants has seen a fall in income at Fisher & Paykel Healthcare as the company approaches its 2022 balance date.
It expects to record operating revenue of between $1.675 billion and $1.7b for the financial year ended March
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
